Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
NITAG documentation
SAGE documentation
2022
Background paper
Clear all
Type of publications
NITAG documentation
(8)
SAGE documentation
(1)
Topics
Background paper
(9)
Regions
Americas
(8)
Countries
United States of America
(8)
Diseases
COVID-19
(9)
Cholera
(2)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(4)
Influenza
(1)
Mpox // Monkeypox
(1)
Pneumococcal disease
(1)
Publication date
2022
(9)
2021
(27)
2020
(48)
Target population
Available to download in languages
English (EN)
(9)
9 results found
2022
∙
ACIP
ACIP Update to the Evidence to Recommendations for a Pfizer-BioNTech COVID-19 Booster in Children Ages 5-11 Years
2022
CDC Clinical Considerations for Second COVID-19 Vaccine Booster Dose
2022
∙
Sara Oliver, ACIP
Evidence to recommendation Framework: mRNA COVID-19 vaccine in young children
2022
∙
ACIP
GRADE for Moderna COVID-19 Vaccine for Children Aged 6 Months–5 Years
2022
∙
ACIP
GRADE for Pfizer-BioNTech COVID-19 Vaccine for Children Aged 6 Months–4 Years
2022
∙
Elisha Hall, ACIP
Interim Clinical Considerations Update for Pediatric COVID-19 Vaccines
2022
∙
SAGE
Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19
2022
∙
ACIP, Kevin Chatham-Stephens
Pediatric COVID-19 Vaccine Planning for Children 6 Months–4 Years
2022
∙
Sara Oliver, ACIP
Updates to the Evidence to Recommendation Framework: Pfizer-BioNTech COVID-19 booster in children aged 5-11 years
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register